Cure SMA, a nonprofit group supporting people with spinal muscular atrophy (SMA) and investing in SMA research, will…
Articles by David Melamed
The EONIS system, a screening assay capable of simultaneously testing newborns for three genetic conditions, including spinal muscular atrophy…
Two years after acquiring the gene therapy company AveXis, Novartis has renamed it Novartis Gene…
Cure SMA has launched a new program to offer medical alert bracelets to spinal muscular atrophy (SMA) patients…